Literature DB >> 1591071

Second malignancies in thyroid cancer patients: a population-based survey of 3658 cases from Norway.

L A Akslen1, E Glattre.   

Abstract

In a population-based survey of 3658 thyroid cancer patients diagnosed in Norway during 1955-85, a total of 200 cases of second malignancies were observed (30,414 person-years, mean follow-up 8.4 years). Male patients had a significantly increased incidence of urogenital cancer [standardised incidence ratio (SIR) = 1.96, 95% confidence interval (CI) 1.4-2.7], including cancer of the testis (SIR = 11.8, 95% CI 3.2-30.1) and urinary bladder (SIR = 3.0, 95% CI 1.5-5.2). The occurrence of malignant melanoma was also increased among males (SIR = 4.2, 95% CI 1.4-9.7). This apparent association with urogenital cancers among males at the present time cannot be explained, although increased surveillance as well as specific aetiological factors should be considered.

Entities:  

Mesh:

Year:  1992        PMID: 1591071     DOI: 10.1016/s0959-8049(05)80085-1

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  5 in total

1.  Risk of second primary cancer following differentiated thyroid cancer.

Authors:  Emmanuelle Berthe; Michel Henry-Amar; Jean-Jacques Michels; Jean-Pierre Rame; Pascaline Berthet; Emmanuel Babin; Philippe Icard; Guy Samama; Françoise Galateau-Sallé; Jacques Mahoudeau; Stéphane Bardet
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-01-28       Impact factor: 9.236

2.  Second Primary Cancer Risk among Kidney Cancer Patients in Korea: A Population-Based Cohort Study.

Authors:  Jae Young Joung; Whi-An Kwon; Jiwon Lim; Chang-Mo Oh; Kyu-Won Jung; Sung Han Kim; Ho Kyung Seo; Weon Seo Park; Jinsoo Chung; Kang Hyun Lee; Young-Joo Won
Journal:  Cancer Res Treat       Date:  2017-04-19       Impact factor: 4.679

3.  Second primary malignancies in thyroid cancer patients.

Authors:  C Rubino; F de Vathaire; M E Dottorini; P Hall; C Schvartz; J E Couette; M G Dondon; M T Abbas; C Langlois; M Schlumberger
Journal:  Br J Cancer       Date:  2003-11-03       Impact factor: 7.640

4.  Second primary neoplasms in thyroid cancer patients.

Authors:  K Ishikawa; S Noguchi; K Tanaka; A Fukuda; T Hirohata
Journal:  Jpn J Cancer Res       Date:  1996-03

Review 5.  Breast Cancer After Treatment of Differentiated Thyroid Cancer With Radioiodine in Young Females: What We Know and How to Investigate Open Questions. Review of the Literature and Results of a Multi-Registry Survey.

Authors:  Christoph Reiners; Rita Schneider; Tamara Platonova; Mikhail Fridman; Uwe Malzahn; Uwe Mäder; Alexis Vrachimis; Tatiana Bogdanova; Jolanta Krajewska; Rossella Elisei; Fernanda Vaisman; Jasna Mihailovic; Gracinda Costa; Valentina Drozd
Journal:  Front Endocrinol (Lausanne)       Date:  2020-07-10       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.